Table:
begin	end	state
1	32	non-cytoplasmic
33	53	transmembrane
54	59	cytoplasmic
60	81	transmembrane
82	99	non-cytoplasmic
100	121	transmembrane
122	129	cytoplasmic
130	152	transmembrane
153	171	non-cytoplasmic
172	199	transmembrane
200	209	cytoplasmic
210	232	transmembrane
233	277	non-cytoplasmic
278	300	transmembrane
301	319	cytoplasmic
320	340	transmembrane
341	346	non-cytoplasmic
347	388	transmembrane
389	407	non-cytoplasmic
408	438	transmembrane
439	559	cytoplasmic

Input:
>15328 FitnessBrowser__Keio:15328
MNKIFSSHVMPFRALIDACWKEKYTAARFTRDLIAGITVGIIAIPLAMALAIGSGVAPQY
GLYTAAVAGIVIALTGGSRFSVSGPTAAFVVILYPVSQQFGLAGLLVATLLSGIFLILMG
LARFGRLIEYIPVSVTLGFTSGIGITIGTMQIKDFLGLQMAHVPEHYLQKVGALFMALPT
INVGDAAIGIVTLGILVFWPRLGIRLPGHLPALLAGCAVMGIVNLLGGHVATIGSQFHYV
LADGSQGNGIPQLLPQLVLPWDLPNSEFTLTWDSIRTLLPAAFSMAMLGAIESLLCAVVL
DGMTGTKHKANSELVGQGLGNIIAPFFGGITATAAIARSAANVRAGATSPISAVIHSILV
ILALLVLAPLLSWLPLSAMAALLLMVAWNMSEAHKVVDLLRHAPKDDIIVMLLCMSLTVL
FDMVIAISVGIVLASLLFMRRIARMTRLAPVVVDVPDDVLVLRVIGPLFFAAAEGLFTDL
ESRLEGKRIVILKWDAVPVLDAGGLDAFQRFVKRLPEGCELRVCNVEFQPLRTMARAGIQ
PIPGRLAFFPNRRAAMADL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server